Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life : A study in patients with disseminated non-seminomatous testicular cancer

R. deWit,Richard Sylvester,C Tsitsa,Phm deMulder,Dt Sleyfer,Wwt Huinink,Stan B. Kaye,At vanOosterom,Epie Boven,K. Vermeylen,Gerrit Stoter

Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life : A study in patients with disseminated non-seminomatous testicular cancer

1997

R. deWit
Richard Sylvester
C Tsitsa
Phm deMulder
Dt Sleyfer
Wwt Huinink
Stan B. Kaye
At vanOosterom
Epie Boven
K. Vermeylen
Gerrit Stoter

Tumour marker concentration at the start of chemotherapy is a stronger predictor of treatment failure than marker half-life: a study in patients with disseminated non-seminomatous testicular cancer

Keywords:

Germ cell tumors
Immunology
Etoposide
Vinblastine
Teratoma
Cancer
Medicine
Testicular cancer
Bleomycin
Chemotherapy
combination chemotherapy
Gonadotropin
Induction chemotherapy
Predictive value of tests

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations